Copyright
©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108063
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108063
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108063
Table 1 Inpatient encounter demographics and clinical characteristics by sex, n (%)
| Attribute | Overall (n = 1386) | Male (n = 875) | Female (n = 511) | P value |
| Age at encounter (years) | 0.0031b | |||
| Median | 46 | 47 | 45 | |
| Range | 24-79 | 25-79 | 24-75 | |
| Age group at encounter | 0.0088b | |||
| ≤ 34 | 197 (14.2) | 112 (12.8) | 85 (16.6) | |
| 35-44 | 423 (30.5) | 260 (29.7) | 163 (31.9) | |
| 45-54 | 449 (32.4) | 277 (31.7) | 172 (33.7) | |
| 55-64 | 266 (19.2) | 188 (21.5) | 78 (15.3) | |
| ≥ 65 | 51 (3.7) | 38 (4.3) | 13 (2.5) | |
| Ethnicity | 0.3009 | |||
| Hispanic/Latino | 38 (2.8) | 21 (2.4) | 17 (3.3) | |
| Non-Hispanic/Latino | 1231 (89.8) | 772 (89.5) | 459 (90.4) | |
| Unknown | 102 (7.4) | 70 (8.1) | 32 (6.3) | |
| BMI (kg/m2) | 0.0127a | |||
| Median | 27.2 | 27.6 | 26.6 | |
| Range | 15.8-69.7 | 17.3-69.7 | 15.8-51.3 | |
| BMI (kg/m2) | 0.2583 | |||
| ≤ 18.5 | 50 (3.6) | 26 (3) | 24 (4.7) | |
| 18.6-24.9 | 450 (32.5) | 272 (31.1) | 178 (34.8) | |
| 25-29.9 | 409 (29.5) | 265 (30.3) | 144 (28.2) | |
| 30-34.9 | 254 (18.3) | 171 (19.5) | 83 (16.2) | |
| 35-39.9 | 133 (9.6) | 85 (9.7) | 48 (9.4) | |
| ≥ 40 | 90 (6.5) | 56 (6.4) | 34 (6.7) | |
| CCI | 0.9201 | |||
| Median | 4 | 4 | 4 | |
| Range | 0-16 | 0-16 | 0-13 | |
| CCI group | 0.1693 | |||
| Mild (≤ 2) | 161 (11.6) | 91 (10.4) | 70 (13.7) | |
| Moderate (3-4) | 628 (45.3) | 405 (46.3) | 223 (43.6) | |
| Severe (≥ 5) | 597 (43.1) | 379 (43.3) | 218 (42.7) | |
| Discriminant function score | 0.2262 | |||
| Median | 41.2 | 39.9 | 42.5 | |
| Range | 0-470 | 0-470 | 2-374 | |
| Discriminant function score | 0.2739 | |||
| < 32 | 503 (36.3) | 327 (37.4) | 176 (34.4) | |
| ≥ 32 | 883 (63.7) | 548 (62.6) | 335 (65.6) | |
| MELD-Na score | 0.3012 | |||
| Median | 41.2 | 39.9 | 42.5 | |
| Range | 11-40 | 11-40 | 11-40 | |
| MELD-Na score | 0.8612 | |||
| < 15 | 89 (6) | 54 (6.2) | 29 (5.7) | |
| 16-20 | 247 (17.8) | 151 (17.3) | 96 (18.8) | |
| 21-22 | 126 (9.1) | 77 (8.8) | 49 (9.6) | |
| 23-26 | 292 (21.1) | 184 (21) | 108 (21.1) | |
| 27-21 | 299 (21.6) | 186 (21.3) | 113 (22.1) | |
| ≥ 32 | 339 (24.5) | 223 (25.5) | 116 (22.7) |
Table 2 Encounter diagnoses and procedures, and disposition by sex, n (%)
| Attribute | Overall (n = 1386) | Male (n = 875) | Female (n = 511) | P value |
| Diagnoses | ||||
| Ascites | 1009 (72.8) | 365 (71.4) | 644 (73.6) | 0.3808 |
| Bacteremia | 89 (6.4) | 62 (7.1) | 27 (5.3) | 0.1867 |
| Clostridium difficile infection | 61 (4.4) | 35 (4) | 26 (5.1) | 0.3407 |
| Esophageal variceal bleed | 121 (8.7) | 96 (11) | 25 (4.9) | 0.0001b |
| Hepatic encephalopathy | 575 (41.5) | 376 (43) | 199 (38.9) | 0.1420 |
| Hepatorenal syndrome | 231 (16.7) | 158 (18.1) | 73 (14.3) | 0.0691 |
| Pneumonia | 234 (16.9) | 138 (15.8) | 96 (18.8) | 0.1483 |
| Portal vein thrombosis | 55 (4) | 40 (4.6) | 15 (2.9) | 0.1323 |
| Spontaneous bacterial peritonitis | 1 (0.1) | 0 | 1 (0.1) | 0.4447 |
| Sepsis | 291 (21) | 167 (19.1) | 124 (24.3) | 0.0223a |
| Substance/alcohol use disorder | 1075 (77.6) | 687 (78.5) | 388 (75.9) | 0.2658 |
| Urinary tract infection | 271 (19.6) | 122 (13.9) | 149 (29.2) | < 0.0001b |
| Medications: | ||||
| Use of any vasopressors | 235 (17) | 137 (15.7) | 98 (19.2) | 0.0919 |
| Norepinephrine | 227 (16.4) | 130 (14.9) | 97 (19) | 0.0453a |
| Epinephrine | 58 (4.2) | 39 (4.5) | 19 (3.7) | 0.5074 |
| Vasopressin | 118 (8.5) | 65 (7.4) | 53 (10.4) | 0.0582 |
| Use of steroids | 503 (36.3) | 328 (37.5) | 175 (34.3) | 0.2263 |
| Use of N-acetylcysteine | 137 (9.9) | 82 (9.4) | 55 (10.8) | 0.4023 |
| Procedures: | ||||
| Renal replacement therapy | 36 (2.6) | 18 (2.1) | 18 (3.5) | 0.0980 |
| Hemodialysis | 10 (0.7) | 8 (0.9) | 2 (0.4) | 0.2671 |
| Mechanical ventilation | 252 (18.2) | 149 (17) | 103 (10.8) | 0.1452 |
| Length of stay (days) | ||||
| Median | 5.6 | 5.5 | 5.7 | 0.4989 |
| Range | 0.1-92.7 | 0.1-92.7 | 0.1-75.7 | |
| Disposition | ||||
| Hospice | 56 (4) | 41 (4.7) | 15 (2.9) | 0.1104 |
| Inpatient death | 150 (10.8) | 93 (10.6) | 57 (11.2) | 0.7610 |
| Inpatient death > 48 hours after admission | 122 (8.8) | 74 (8.5) | 48 (9.4) | 0.5529 |
| Inpatient death or hospice | 206 (14.9) | 134 (15.3) | 72 (14.1) | 0.5365 |
Table 3 Logistic regression analysis of odds of encounter mortality
| Attribute | Odds ratio | 95%CI | P value |
| Age group (≤ 34 as referent) | |||
| 35-44 | 1.57 | 0.686-3.592 | 0.2855 |
| 45-54 | 3.128 | 1.410-6.939 | 0.005b |
| 55-64 | 2.732 | 1.163-6.418 | 0.0211a |
| ≥ 65 | 4.318 | 1.124-16.589 | 0.0331a |
| MELD-Na score (≤ 15 as referent) | |||
| 16-20 | 1.163 | 0.119-11.311 | 0.8967 |
| 21-22 | 0.264 | 0.014-4.908 | 0.3717 |
| 23-26 | 2.41 | 0.282-20.596 | 0.4217 |
| 27-31 | 1.981 | 0.235-16.722 | 0.5300 |
| ≥ 32 | 6.925 | 0.851-56.355 | 0.0704 |
| Diagnoses | |||
| Hepatic encephalopathy | 2.308 | 1.403-3.797 | 0.0010b |
| Hepatorenal syndrome | 2.224 | 1.394-3.551 | 0.0008b |
| Pneumonia | 2.078 | 1.276-3.382 | 0.0033b |
| Sepsis | 2.309 | 1.419-3.757 | 0.0008b |
| Procedures | |||
| Mechanical ventilation | 9.301 | 5.724-15.114 | < 0.0001b |
Table 4 Logistic regression analysis of odds of encounter sepsis
| Attribute | Odds ratio | 95%CI | P value |
| Sex | |||
| Female | 1.41 | 1.064-1.869 | 0.0168a |
| Age group (≤ 34 as referent) | |||
| 35-44 | 0.593 | 0.383-0.917 | 0.0189a |
| 45-54 | 0.603 | 0.394-0.921 | 0.0192a |
| 55-64 | 0.577 | 0.357-0.93 | 0.0248a |
| ≥ 65 | 0.263 | 0.106-0.652 | 0.0039b |
| CCI [Mild (≤ 2) as referent] | |||
| Moderate (3-4) | 2.003 | 1.054-3.809 | 0.0340a |
| Severe (≥ 5) | 3.6 | 1.886-6.874 | 0.0001b |
| Discriminant function score (< 32 as referent) | |||
| ≥ 32 | 1.669 | 1.130-2.467 | 0.0101a |
| MELD-Na score (≤ 15 as referent) | |||
| 16-20 | 0.675 | 0.266-1.717 | 0.4097 |
| 21-22 | 0.929 | 0.342-2.525 | 0.8854 |
| 23-26 | 1.323 | 0.539-3.249 | 0.5409 |
| 27-31 | 2.07 | 0.846-5.065 | 0.1111 |
| ≥ 32 | 3.12 | 1.272-7.653 | 0.0129a |
Table 5 Logistic regression analysis of odds of encounter mechanical ventilation
| Attribute | Odds ratio | 95%CI | P value |
| Sex | |||
| Female | 1.352 | 1.006-1.816 | 0.0168a |
| CCI [Mild (≤ 2) as referent] | |||
| Moderate (3-4) | 6.717 | 2.081-21.680 | 0.0014b |
| Severe (≥ 5) | 13.535 | 4.221-43.405 | < 0.0001b |
| MELD-Na score (≤ 15 as referent) | |||
| 16-20 | 1.223 | 0.437-3.425 | 0.7018 |
| 21-22 | 1.349 | 0.443-4.109 | 0.5986 |
| 23-26 | 2.139 | 0.804-5.690 | 0.1275 |
| 27-31 | 3.074 | 1.173-8.06 | 0.0224a |
| ≥ 32 | 5.392 | 2.087-13.934 | 0.0005a |
- Citation: Harris E, Rhudy C, Roy L, Cloud A, Leyson CD. Sex differences in severity, outcomes, and healthcare utilization in alcohol-associated hepatitis. World J Hepatol 2025; 17(8): 108063
- URL: https://www.wjgnet.com/1948-5182/full/v17/i8/108063.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i8.108063
